0001209191-15-064032.txt : 20150805 0001209191-15-064032.hdr.sgml : 20150805 20150805161844 ACCESSION NUMBER: 0001209191-15-064032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150804 FILED AS OF DATE: 20150805 DATE AS OF CHANGE: 20150805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SACHS BRUCE I CENTRAL INDEX KEY: 0001197036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 151029212 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-04 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197036 SACHS BRUCE I C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2015-08-04 4 M 0 10000 34.24 A 31210 D Common Stock 2015-08-04 4 S 0 10000 140.13 D 21210 D Stock Option (right to buy) 34.24 2015-08-04 4 M 0 10000 0.00 D 2020-05-31 Common Stock 10000 10000 D Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $140.13 (range $140.00 to $140.45). Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Fully vested. Omar White, Attorney-In-Fact 2015-08-05